 |
|
|
| |
TLR7 Agonist GS-9620 is a Potent Inhibitor of
Acute HIV-1 Infection in Human PBMCs
|
| |
| |
Reported by Jules Levin
IAS 2015 Vancouver July 19-22
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2015 Vancouver, British Columbia, Canada
RA Bam*, GS Jones, A Irrinki, J Hesselgesser, CR Frey, T Cihlar and SR Yant
Gilead Sciences, Inc., Foster City, CA
TLR7 Nature Immunology research paper & Commentary - (03/13/15)
A surprising role for TLR7......
CROI: TLR7 Agonist GS-9620 Activates HIV-1 in PBMCs from HIV-Infected Patients on cART - (02/26/15)
CROI: Treatment with a TLR7 Agonist Induces Transient Viremia in SIV-Infected ART-Suppressed Monkeys - (02/27/15)
|
| |
|
|
|
|
|
